151 related articles for article (PubMed ID: 10718331)
21. Photodynamic therapy in the canine prostate using motexafin lutetium.
Hsi RA; Kapatkin A; Strandberg J; Zhu T; Vulcan T; Solonenko M; Rodriguez C; Chang J; Saunders M; Mason N; Hahn S
Clin Cancer Res; 2001 Mar; 7(3):651-60. PubMed ID: 11297261
[TBL] [Abstract][Full Text] [Related]
22. Photodynamic therapy for neovascular age-related macular degeneration.
Wormald R; Evans J; Smeeth L
Cochrane Database Syst Rev; 2000; (2):CD002030. PubMed ID: 10796845
[TBL] [Abstract][Full Text] [Related]
23. Approaches toward combining photodynamic therapy with pharmaceuticals that alter vascular microenvironment.
Busch T
Retina; 2009 Jun; 29(6 Suppl):S36-8. PubMed ID: 19553798
[TBL] [Abstract][Full Text] [Related]
24. Photoangioplasty for human peripheral atherosclerosis: results of a phase I trial of photodynamic therapy with motexafin lutetium (Antrin).
Rockson SG; Kramer P; Razavi M; Szuba A; Filardo S; Fitzgerald P; Cooke JP; Yousuf S; DeVault AR; Renschler MF; Adelman DC
Circulation; 2000 Nov; 102(19):2322-4. PubMed ID: 11067782
[TBL] [Abstract][Full Text] [Related]
25. Preclinical evaluation of motexafin lutetium-mediated intraperitoneal photodynamic therapy in a canine model.
Griffin GM; Zhu T; Solonenko M; Del Piero F; Kapakin A; Busch TM; Yodh A; Polin G; Bauer T; Fraker D; Hahn SM
Clin Cancer Res; 2001 Feb; 7(2):374-81. PubMed ID: 11234893
[TBL] [Abstract][Full Text] [Related]
26. Gd-Tex Pharmacyclics Inc.
Radford IR
Curr Opin Investig Drugs; 2000 Dec; 1(4):524-8. PubMed ID: 11249709
[TBL] [Abstract][Full Text] [Related]
27. Photodynamic therapy using Lu-Tex induces apoptosis in vitro, and its effect is potentiated by angiostatin in retinal capillary endothelial cells.
Renno RZ; Delori FC; Holzer RA; Gragoudas ES; Miller JW
Invest Ophthalmol Vis Sci; 2000 Nov; 41(12):3963-71. PubMed ID: 11053300
[TBL] [Abstract][Full Text] [Related]
28. Photodynamic therapy for age-related macular degeneration.
Franks W
Age Ageing; 2002 Jan; 31(1):5-6. PubMed ID: 11850299
[No Abstract] [Full Text] [Related]
29. Phthalocyanine-based photosensitizers: more efficient photodynamic therapy?
Ng DK
Future Med Chem; 2014; 6(18):1991-3. PubMed ID: 25531964
[No Abstract] [Full Text] [Related]
30. [New methods of treatment of age-related macular degeneration. Photodynamic therapy. Part I].
Gierek-Łapińska A; Wykrota H; Trzciakowski K
Klin Oczna; 2002; 104(3-4):276-82. PubMed ID: 12608319
[TBL] [Abstract][Full Text] [Related]
31. In vivo light dosimetry for motexafin lutetium-mediated PDT of recurrent breast cancer.
Dimofte A; Zhu TC; Hahn SM; Lustig RA
Lasers Surg Med; 2002; 31(5):305-12. PubMed ID: 12430147
[TBL] [Abstract][Full Text] [Related]
32. [Photodynamic therapy of age-related macular degeneration].
Jaakkola A
Duodecim; 2002; 118(8):813-9. PubMed ID: 12238196
[No Abstract] [Full Text] [Related]
33. Photodynamic therapy in age-related macular degeneration: missing information.
Wenkstern A; Stokes J
Age Ageing; 2003 May; 32(3):357-9. PubMed ID: 12720631
[No Abstract] [Full Text] [Related]
34. Photodynamic therapy of age-related macular degeneration: History and principles.
van den Bergh H
Semin Ophthalmol; 2001 Dec; 16(4):181-200. PubMed ID: 15513440
[TBL] [Abstract][Full Text] [Related]
35. Effects of texaphyrins on the oxygenation of EMT6 mouse mammary tumors.
Donnelly ET; Liu Y; Fatunmbi YO; Lee I; Magda D; Rockwell S
Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1570-6. PubMed ID: 15050338
[TBL] [Abstract][Full Text] [Related]
36. [Photodynamic therapy with Vsudyne (Verteporfin)--an innovative therapy of age-related macular degeneration].
Augustin AJ
Krankenpfl J; 2000 Oct; 38(9-10):342-3. PubMed ID: 11194354
[No Abstract] [Full Text] [Related]
37. [Photodynamic therapy carefully destroys neovascularization of the retina].
Ophthalmologe; 2003 Feb; 100(2):1 p following 174. PubMed ID: 12650171
[No Abstract] [Full Text] [Related]
38. Photodynamic therapy with motexafin lutetium for rectal cancer: a preclinical model in the dog.
Ross HM; Smelstoys JA; Davis GJ; Kapatkin AS; Del Piero F; Reineke E; Wang H; Zhu TC; Busch TM; Yodh AG; Hahn SM
J Surg Res; 2006 Oct; 135(2):323-30. PubMed ID: 16650871
[TBL] [Abstract][Full Text] [Related]
39. Current clinical and preclinical photosensitizers for use in photodynamic therapy.
Detty MR; Gibson SL; Wagner SJ
J Med Chem; 2004 Jul; 47(16):3897-915. PubMed ID: 15267226
[No Abstract] [Full Text] [Related]
40. Motexafin gadolinium: a redox-active tumor selective agent for the treatment of cancer.
Evens AM
Curr Opin Oncol; 2004 Nov; 16(6):576-80. PubMed ID: 15627019
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
